Today's Sponsors | | Sponsored | | |  | FDA Approval Could Send this Stock Soaring | | Whenever the FDA approves a new drug...
Timely investors could see 300-400% returns...
ChemoCentryx soared 281% in the year after it won FDA approval...
Immunogen jumped 449% in the two years after it won FDA approval...
Even Krystal Biotech rose 242% when it looked like it would win FDA approval, which it did.
Here's the next stock we think has a good chance of winning FDA approval >>> | |  | Buy this stock for 2026 (And sell this one)
| | Will you potentially make money or lose money in the U.S. stock market in 2026?
According to the 50-year Wall Street legend who invented one of Wall Street's most popular buying and selling indicators – the answer has nothing to do with AI, quantum computing, or cryptos.
Instead, it all comes down to the #1 stock he recommends you BUY now…
And the #1 stock he recommends you SELL now. | | | | | Precious metals cash in on record run, stocks bask in year-end glow | | Dec 31, 2025 | | There was a last-minute selloff in precious metals markets on Wednesday as investors cashed in some of the year's massive gains in gold, silver and platinum, while stocks quietly consolidated their best year since before the COVID pandemic.
Read more | Want to Spot Small-Caps Before They Move? | | Sponsored | | Big moves in small-caps don't start with the headlines. They start with signals—volume, float, momentum.
We just released a short guide that walks you through exactly how we spot these setups early—before the crowd catches on.
Think moves like QNRX before its 200% pop, or TOP before its volatility spike.
👉 [Tap here to grab your free Small-Cap Playbook]
(By clicking the links above, you will opt in you in to receive emails from Krypton Street newsletter. Unsubscribing is easy. Privacy policy)
P.S. Krypton Street has not been compensated for covering QNRX or TOP and does not own shares in the company. Our goal is to provide insights to help support your investment research. Keep in mind that investing in securities is risky and you should always consult with an investment professional before investing. We are not investment advisors or registered brokers.
| | Drugmakers raise US prices on 350 medicines despite pressure from Trump | | Dec 31, 2025 | | Drugmakers plan to raise U.S. prices on at least 350 branded medications including vaccines against COVID, RSV and shingles and blockbuster cancer treatment Ibrance, even as the Trump administration pressures them for cuts, according to data provided exclusively by healthcare research firm 3 Axis Advisors.
Read more | | 2 Biotech Stocks With Key FDA Decisions on the Horizon
| | Dec 31, 2025 | | Biotech stocks have a way of going quiet right before they don't. Long stretches of sideways trading can suddenly give way to sharp moves…not because of earnings or macro headlines, but because a single regulatory decision changes the outlook overnight.
Read more | | | From Our Partners | | Sponsored | | |  | Which stock will the White House buy next? | | Insiders in Washington have already bought massive stakes in three tiny resource firms, driving them up as much as 200% overnight. Now, the man who recommended MP Materials before the White House bought (making 100% for his followers) is naming the next stocks he believes the government will target.
Get the names and tickers right here – free of charge. | |  | REVEALED: Something Big Happening West of Pittsburgh | | What I just learned about the situation unfolding in Appalachia is stunning…
And you need to see it for yourself.
Once you see what's really going on in small town America, you'll understand why I rushed this interview to you today.
Click here to watch this video | | | This Week's Top Market Headlines | | | | | This Week's Top AI Headlines | | | | | This Week's Top Crypto Headlines | | | | | | | 2025 Meza Media LLC All Rights Reserved. 1001 Fischer Blvd Suite 3, #114
Toms River, NJ 08753 | | | | | | DISCLAIMER: This communication includes advertising material and PAID ADVERTISEMENTS provided to our customers. Stocks and options trading have large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stocks and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell stocks or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed in this report. The past performance of any trading system or methodology is not necessarily indicative of future results. All trades, patterns, charts, systems, etc., discussed in this report are for illustrative purposes only and not to be construed as specific advisory recommendations. Information contained in this correspondence is intended for informational purposes only and was obtained from sources believed to be reliable. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted. | | | | |
No comments:
Post a Comment